Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Seelos Therapeutics (SEEL) has announced the participation of Acadia Healthcare (ACHC) in a registration-directed Proof of Concept study for SLS-002, intranasal racemic ketamine, targeting Acute Suicidal Ideation and Behavior (ASIB) in patients with Major Depressive Disorder (MDD). This collaborative effort seeks to evaluate the efficacy and safety of SLS-002 in patients at imminent risk of suicide. Acadia operates a well-established network of behavioral health facilities, treating thousands daily, enhancing the study's potential impact.
Acadia Healthcare Company (NASDAQ: ACHC) reported second-quarter financial results for 2022, showcasing a revenue of $651.7 million, a rise of 11.9% year-over-year. Net income hit $80.1 million, translating to $0.88 per diluted share. Adjusted EBITDA reached $165.9 million, or $157.3 million when excluding income from the Provider Relief Fund (PRF). The company is on track to add 300 beds by year-end and anticipates continued growth in behavioral healthcare services. Acadia raised its 2022 guidance for revenue between $2.56 to $2.60 billion.
Acadia Healthcare Company (NASDAQ: ACHC) has announced a joint venture with ECU Health to build a 144-bed behavioral health hospital in Greenville, North Carolina. Set to open in spring 2025, the facility will include 24 inpatient beds specifically for children and adolescents, the first in ECU Health's service area. The joint investment is approximately $65 million, aimed at enhancing behavioral health resources in eastern North Carolina. This facility will also function as a teaching hospital, supporting the training of medical students and residents.
Acadia Healthcare and ECU Health will build a new 144-bed behavioral health hospital in Greenville, North Carolina, set to open in spring 2025. This facility is part of a joint investment of approximately $65 million and aims to enhance access to behavioral health services for the community. The hospital will provide specialized care, including 24 beds for children and adolescents, the first of their kind in the region. Construction is expected to start in 2023, pending regulatory approvals, and aligns with a growing need for mental health resources in North Carolina.
Acadia Healthcare Company (NASDAQ: ACHC) plans to release its Q2 2022 results on July 27, 2022, post-market close. Subsequently, a conference call for investors and analysts is scheduled for July 28, 2022, at 9:00 a.m. ET, with a live webcast available on their website. As of March 31, 2022, Acadia operates 238 facilities with around 10,600 beds across 40 states and Puerto Rico, serving approximately 70,000 patients daily, making it the largest stand-alone behavioral health company in the U.S.
Tufts Medicine and Acadia Healthcare have announced a joint venture to develop a 144-bed inpatient behavioral health facility in Malden, Massachusetts, with a total investment of $65 million. This facility aims to enhance access to high-quality behavioral health services for patients of all ages in the Greater Boston area. The new hospital will replace the former Malden Hospital and include comprehensive inpatient and intensive outpatient care programs. This initiative addresses the growing demand for behavioral health services, particularly for adolescents facing long wait times in emergency departments.
Acadia Healthcare Company (NASDAQ: ACHC) has announced a joint venture with Tufts Medicine to establish a new 144-bed behavioral health hospital in Malden, Massachusetts. The facility aims to enhance access to vital inpatient behavioral health services, supported by an investment exceeding $65 million. This new hospital will cater to patients of all ages and will also serve as a teaching hospital for Tufts University students. The joint venture marks Acadia's 17th partnership and underscores its commitment to addressing mental health care needs in the community.
Acadia Healthcare Company (NASDAQ: ACHC) announces the appointment of R. David Kelly as an independent director on its Board of Directors. Kelly brings over 35 years of experience in financial advisory and real estate development. He founded StraightLine Realty Partners and previously held significant positions at Goldman Sachs and Trammell Crow Company. His extensive background includes serving as chairman of the $197B Teacher’s Retirement System of Texas. Acadia aims to leverage Kelly's expertise to enhance strategic investments and growth in behavioral healthcare services.
Acadia Healthcare Company (NASDAQ: ACHC) announced its participation in two major healthcare conferences in May 2022. On May 11, it will present at the BofA Securities 2022 Healthcare Conference in Las Vegas at 3:20 p.m. PT. Later, on May 24, it will speak at the UBS Global Healthcare Conference in New York at 2:00 p.m. ET. The live presentations will be accessible via webcast on its website, with replays available for 30 days. Acadia, a leading behavioral healthcare provider, operates 238 facilities across the U.S. and Puerto Rico, serving 70,000 patients daily.
Acadia Healthcare Company (ACHC) announced its Q1 2022 financial results, reporting a revenue of $616.7 million, an 11.9% increase year-over-year. Same facility revenue also rose by 8.6%, supported by a 6.2% increase in revenue per patient day. Net income reached $60.8 million, or $0.67 per diluted share. The company is expanding its facilities, adding 28 beds and planning for over 300 beds in total this year. Acadia affirmed its 2022 guidance, projecting revenue between $2.55 to $2.60 billion.